| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0009 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.001 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.001 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.002 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.16 | 0.002 |